Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada
Abdel Aziz Shaheen, Kristine Kong, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 5, pp. e1170-e1179
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Liver Transplantation 2023: Status Report, Current and Future Challenges
Norah A. Terrault, Claire Francoz, Marina Berenguer, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2150-2166
Open Access | Times Cited: 117
Alcohol Sales and Adverse Events during the Covid-19 Pandemic
Wid Yaseen, Alex Kiss, Justin Chau, et al.
NEJM Evidence (2025) Vol. 4, Iss. 3
Closed Access | Times Cited: 1
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Covid-19 and alcohol associated liver disease
Sasha Deutsch‐Link, Brenda Curtis, Ashwani K. Singal
Digestive and Liver Disease (2022) Vol. 54, Iss. 11, pp. 1459-1468
Open Access | Times Cited: 38
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Epidemiology and trends of alcohol use disorder and alcohol-associated liver disease
Elizabeth Lee, Huttakan Navadurong, Suthat Liangpunsakul
Clinical Liver Disease (2023) Vol. 22, Iss. 3, pp. 99-102
Open Access | Times Cited: 13
Persisting challenges in the early detection of hepatocellular carcinoma
Ashwini Arvind, K. Redmon, Amit G. Singal
Expert Review of Anticancer Therapy (2025)
Closed Access
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
Romina Roshanshad, Amirhossein Roshanshad, Reza Fereidooni, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 441-459
Open Access | Times Cited: 10
HPA axis function in alcohol use disorder: A systematic review and meta-analysis
Neil Dunne, Jo‐Hanna Ivers
Addiction Neuroscience (2023) Vol. 8, pp. 100114-100114
Open Access | Times Cited: 10
Management of alcoholic hepatitis: A clinical perspective
Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2078-2095
Open Access | Times Cited: 10
Review article: current and emerging therapies for acute alcohol‐associated hepatitis
Puru Rattan, Vijay H. Shah
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 1, pp. 28-40
Closed Access | Times Cited: 14
Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice
Afroza Ferdouse, Robin D. Clugston
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
Risk of mortality among patients with alcohol-associated hepatitis in the US from 2007 to 2021
Wanzhu Tu, Suthat Liangpunsakul, Chi Mai Nguyen, et al.
Alcohol (2024) Vol. 120, pp. 143-150
Closed Access | Times Cited: 2
Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis
Binu V. John, A. Sidney Barritt, Andrew M. Moon, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 10, pp. 2405-2408.e3
Open Access | Times Cited: 12
A nationwide study of liver disease hospitalizations during the coronavirus pandemic in the United States
Mary Sedarous, Michael Youssef, Ayooluwatomiwa D. Adekunle, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 7, pp. 1148-1157
Closed Access | Times Cited: 6
Exploration of the link between COVID‐19 and alcoholic hepatitis from the perspective of bioinformatics and systems biology
Tengda Huang, Bingxuan Yu, Xinyi Zhou, et al.
MedComm – Future Medicine (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 6
Alcoholic Hepatitis
Pranav Penninti, Ayooluwatomiwa D. Adekunle, Ashwani K. Singal
Medical Clinics of North America (2023) Vol. 107, Iss. 3, pp. 533-554
Closed Access | Times Cited: 5
Therapeutic Pipeline in Alcohol-Associated Liver Disease
Nimish Thakral, Sasha Deutsch‐Link, Ashwani K. Singal
Seminars in Liver Disease (2022) Vol. 43, Iss. 01, pp. 060-076
Open Access | Times Cited: 8
Increased mortality in patients with alcohol-induced pancreatitis during the COVID-19 pandemic
Hunza Chaudhry
Annals of Gastroenterology (2022)
Open Access | Times Cited: 8
Emergency services utilization by patients with alcohol‐associated hepatitis: An analysis of national trends
Shreya Sengupta, Akhil Anand, Rocío López, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 1, pp. 98-109
Closed Access | Times Cited: 1
The trends and incidence of alcohol-associated hepatitis hospitalizations from 2016–2020 and the impact of the COVID-19 pandemic
Megan B. Ghai, Pooja Rangan, Naim Alkhouri, et al.
Alcohol (2024) Vol. 121, pp. 177-184
Closed Access | Times Cited: 1
Quality standards on management of alcohol-related liver disease from the UK—targets and tribulations
Bryce Tkachuk, Stephen E. Congly
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 2, pp. 336-342
Open Access | Times Cited: 1
Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
Robert J. Wong
Metabolism and Target Organ Damage (2024)
Open Access | Times Cited: 1
Epidemiology and Outcomes of Alcohol-Associated Hepatitis in Adolescents and Young Adults
Jennifer A. Flemming, Maya Djerboua, O. L. Chapman, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2452459-e2452459
Open Access | Times Cited: 1
Inequity in end‐of‐life care for patients with chronic liver disease in England
Hazel Woodland, Ryan Buchanan, Andy Pring, et al.
Liver International (2023) Vol. 43, Iss. 11, pp. 2393-2403
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top